Press Release Distribution Service | Newswire
Newswire is a platform for distributing news and press releases in Canada. It offers resources for journalists, products for PR professionals, and trending topics for various industries and sectors.
Cision | News Releases - Newswire
Current news releases distributed by Cision in Canada including multimedia press releases, investor relations and disclosure, and company news.
Canadian Migraine Sufferers Have New Treatment Option
Nov 16, 2022 · UBRELVY® is the first oral CGRP receptor antagonist (gepant) approved by Health Canada for the acute treatment of migraine. It reduces or eliminates migraine pain with a single tablet, with the ...
All News Releases | Cision Canada - Newswire
3 days ago · All News Releases. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health ...
Health Canada approves Wegovy™ for the treatment of adults
Nov 25, 2021 · 1 Wegovy™ (semaglutide injection), Novo Nordisk Canada Inc., Product Monograph, November 2021 . 2 Twells LK, Janssen I, Kuk JL. Canadian Adult Obesity Clinical Practice Guidelines: Epidemiology ...
Cision: Contact Cision in Canada - Newswire
* By submitting your information, you agree that Cision may use your information to contact you with marketing communications (newsletters, webinar invitations, event invitations, product ...
Equitable Bank completes acquisition of Concentra Bank - Newswire
Nov 1, 2022 · EQB Inc., the parent company of Canada's Challenger Bank, announces the completion of the acquisition of Concentra Bank for $35.7 million. The deal adds $13.6 billion in assets under management ...
RBC completes acquisition of HSBC Bank Canada - Newswire
Mar 29, 2024 · RBC announces the closing of the deal to buy HSBC Canada, which adds 780,000 clients and 4,500 employees to its personal and commercial banking business. The acquisition will create new jobs ...
Nestlé Canada Releases its Latest Snapshot of its Purpose
NORTH YORK, ON, Aug. 24, 2022 /CNW/ - Nestlé Canada is pleased to issue its 2021/2022 Creating Shared Value (CSV) Snapshot, which highlights the company's efforts to continuously progress in ...
Health Canada approves RYBELSUS® (semaglutide tablets) the
Apr 9, 2020 · RYBELSUS® is the first oral GLP-1 analogue for type 2 diabetes, available in Canada since April 2020. It has been shown to reduce A1C and weight, and has a safe and well-tolerated profile.